Doctor weeps while telling jury about meningitis victims
The Tennessean-7 hours ago
... the president and part owner of the New England Compounding Center, the company blamed for the 2012 outbreak which sickened some 778 patients, killing ...
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Friday, January 20, 2017
Thursday, January 19, 2017
FDA issues final 503A compounding guidance prohibiting office use
Pharmacy Today, American Pharmacists Association, pharmacist.com-Jan 17, 2017
APhA already has submitted joint comments with other pharmacy organizations and stakeholders to the incoming Trump administration opposing the final ...
Roaches, Mold and Dust, Oh My..The FDA issued a new report detailing the results of 350 compounding pharmacy inspections that found numerous “insanitary” conditions
Roaches, Mold and Dust, Oh My
Pharmacy Practice News-Jan 18, 2017
The FDA issued a new report detailing the results of 350 compounding pharmacy inspections that found numerous “insanitary” conditions, including mold, ...
Imprimis Pharmaceuticals, Inc. (IMMY) Valuation According To ...
UK Market News-11 hours ago
Imprimis Pharmaceuticals, Inc. (Imprimis) is engaged in the development, production and dispensing of compounded pharmaceuticals. The Company operates ...
Adamis Pharmaceuticals Announces FDA Acceptance of ...
GlobeNewswire (press release)-9 hours ago
The Company's U.S. Compounding, Inc. subsidiary, which is registered as a drug compounding outsourcing facility under Section 503B of the U.S. Food, Drug ...
Wells Pharmacy Network Completes 503A Building Expansion
Benzinga-6 hours ago
Wells Pharmacy Network announced the completion of a multi-million dollar 5,000 SF expansion and facility enhancement of their 503A compounding pharmacy ...
Update of CVM's What's New - A Guide for Producers – Cattle Estrous Cycle and FDA-Approved Drugs to Control and Synchronize EstrusK
A good understanding of the normal estrous cycle in cattle can help producers address reproductive challenges in both heifers (young female dairy or beef animals that have not yet had their first calf) and cows (female dairy or beef animals that have had at least one calf). This understanding is also critical when using a drug regimen to control and synchronize estrous cycles in cattle.
Subscribe to:
Posts (Atom)